Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Myelin-oligodendrocyte glycoprotein antibody-associated disease

R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

[HTML][HTML] Myelin in the central nervous system: structure, function, and pathology

C Stadelmann, S Timmler… - Physiological …, 2019 - journals.physiology.org
Oligodendrocytes generate multiple layers of myelin membrane around axons of the central
nervous system to enable fast and efficient nerve conduction. Until recently, saltatory nerve …

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

M Reindl, P Waters - Nature Reviews Neurology, 2019 - nature.com
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …

Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing

E Sechi, M Buciuc, SJ Pittock, JJ Chen, JP Fryer… - JAMA …, 2021 - jamanetwork.com
Importance Myelin oligodendrocyte glycoprotein-IgG1–associated disorder (MOGAD) is a
distinct central nervous system–demyelinating disease. Positive results on MOG-IgG1 …

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

R Höftberger, Y Guo, EP Flanagan… - Acta …, 2020 - Springer
We sought to define the pathological features of myelin oligodendrocyte glycoprotein (MOG)
antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We …

Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody–associated disease

A CoboCalvo, A Ruiz, F Rollot… - Annals of …, 2021 - Wiley Online Library
Objective The main objective was to compare clinical features, disease course, and myelin
oligodendrocyte glycoprotein (MOG) antibody (Ab) dynamics between children and adults …

Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody

D Dubey, SJ Pittock, KN Krecke, PP Morris… - JAMA …, 2019 - jamanetwork.com
Importance Recognizing the characteristics of myelin oligodendrocyte glycoprotein
autoantibody (MOG-IgG) myelitis is essential for early accurate diagnosis and treatment …

International multicenter examination of MOG antibody assays

M Reindl, K Schanda, M Woodhall, F Tea… - Neurology …, 2020 - AAN Enterprises
Objective To compare the reproducibility of 11 antibody assays for immunoglobulin (Ig) G
and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 …